Because TICs are resistant to many therapies, and can give rise to tumor relapse, much attention has been given to targeting them for treatment.5,6 PD-L1 and PD-1 are expressed on TICs,7–10 but definitive evidence for their roles in TIC generation has not been reported to our knowledge. The gene discussed is CD274; the disease is neoplasm.